WHITNEY DAILEY: Open Payments
NPI 1063808699 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$527 in 10 payments from 6 companies in 2025. Trend: 2023 $729 · 2024 $1,250 · 2025 $527
Food & beverage: $527
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $135 |
| Astellas Pharma US Inc | 1 | $130 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $122 |
| ABBVIE INC. | 3 | $68 |
| Novo Nordisk Inc | 2 | $42 |
| Amgen Inc. | 2 | $30 |
Products named: INGREZZA, Veozah, Kerendia, UBRELVY, Ozempic, OTEZLA.
Industry payments across FL — which companies pay providers there.
